These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10749917)

  • 1. Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
    Reni M; Ferreri AJ; Landoni C; Villa E
    J Natl Cancer Inst; 2000 Apr; 92(7):575-6. PubMed ID: 10749917
    [No Abstract]   [Full Text] [Related]  

  • 2. Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response.
    Lerro KA; Lacy J
    J Neurooncol; 2002 Sep; 59(2):165-8. PubMed ID: 12241110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma--case report.
    Makino K; Nakamura H; Kudo M; Takeshima H; Kuratsu J
    Neurol Med Chir (Tokyo); 2007 May; 47(5):229-32. PubMed ID: 17527051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
    Enting RH; Demopoulos A; DeAngelis LM; Abrey LE
    Neurology; 2004 Sep; 63(5):901-3. PubMed ID: 15365145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide for relapsed primary CNS lymphoma.
    Osmani AH; Masood N
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):594-5. PubMed ID: 22980617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
    Hargrave D; Bouffet E; Gammon J; Becker L; Rutka J; Baruchel S
    Med Pediatr Oncol; 2003 Dec; 41(6):562-4. PubMed ID: 14595716
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
    Benjelloun A; Delavelle J; Lazeyras F; Dietrich PY
    Neurology; 2001 Nov; 57(10):1932-3. PubMed ID: 11723300
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical response following adjuvant Temozolomide in a patient with primary cerebral lymphoma.
    Strik HM; Spreer A; Nagel H; Jacob S; Jung W; Kitze B; Bähr M
    Anticancer Res; 2004; 24(6):4121-5. PubMed ID: 15736462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10 questions about temozolomide and the treatment of brain tumors.
    Pruitt AA; Rosenfeld MR
    Neurologist; 2005 Nov; 11(6):362-5. PubMed ID: 16286879
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide.
    Pitini V; Baldari S; Altavilla G; Arrigo C; Naro C; Perniciaro F
    J Neurooncol; 2007 Jul; 83(3):291-3. PubMed ID: 17245621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide.
    Bertero L; Cassoni P; Rudà R
    J Neurooncol; 2015 Jan; 121(1):225-7. PubMed ID: 25189790
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.
    Clark SW; Taylor J; Wang DL; Abramson JS; Batchelor TT
    Neurology; 2013 Jul; 81(1):93-4. PubMed ID: 23685934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review.
    Dinnes J; Cave C; Huang S; Major K; Milne R
    Health Technol Assess; 2001; 5(13):1-73. PubMed ID: 11359682
    [No Abstract]   [Full Text] [Related]  

  • 14. Response of low-grade oligodendroglial tumors to temozolomide.
    Byrne TN
    J Neurooncol; 2004 Dec; 70(3):279-80. PubMed ID: 15662968
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of brain metastases of malignant melanoma with temozolomide.
    Biasco G; Pantaleo MA; Casadei S
    N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
    [No Abstract]   [Full Text] [Related]  

  • 16. Temozolomide as prophylaxis for melanoma brain metastases.
    Conill C; González-Cao M; Jorcano S; Puig S; Malvehy J; Martí R; Castel T
    Melanoma Res; 2004 Feb; 14(1):73-4. PubMed ID: 15091198
    [No Abstract]   [Full Text] [Related]  

  • 17. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral temozolomide approved for refractory brain tumor.
    Miller JL
    Am J Health Syst Pharm; 1999 Oct; 56(19):1910. PubMed ID: 10554903
    [No Abstract]   [Full Text] [Related]  

  • 19. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.
    Ngo L; Nei M; Glass J
    Epilepsia; 2006 Jul; 47(7):1237-8. PubMed ID: 16886989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide as salvage treatment in primary brain lymphomas.
    Reni M; Zaja F; Mason W; Perry J; Mazza E; Spina M; Bordonaro R; Ilariucci F; Faedi M; Corazzelli G; Manno P; Franceschi E; Pace A; Candela M; Abbadessa A; Stelitano C; Latte G; Ferreri AJ
    Br J Cancer; 2007 Mar; 96(6):864-7. PubMed ID: 17325700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.